Driving Concepts of Cardiovascular (CV) Nuclear Imaging in the Current Era & Update on CV Molecular Imaging 2011

Saturday, June 4 | 8:00 AM - 12:00 PM
Ballroom C2

Objectives
Upon completion of this activity, the participant will be able to:
1. Discuss key concepts that are predicted to drive the clinical utility of cardiovascular nuclear medicine in the current era.
2. Explain the impact of cost constraints.
3. Identify risks and benefits of radionuclide cardiovascular imaging.
4. Discuss current concepts of vascular molecular imaging.

Speakers are:
Mehran M. Sadeghi, MD, Yale University School of Medicine in New Haven, Conn.;
Ronald G. Schwartz, MD, University of Rochester Medical Center in Rochester, N.Y.;
Robert A. deKemp, PhD, University of Ottawa Heart Institute in Ottawa, Ontario;
Marcelo F. Di Carli, MD, Brigham & Women's Hospital in Boston;
Jamshid Maddahi, MD, University of California, Los Angeles;
H. William Strauss, MD, Memorial Sloan Kettering Cancer Center & Memorial Hospital in New York City; and
Daniel S. Berman, MD, Cedars-Sinai Medical Center in Los Angeles.

Around the web

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.